NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA study in NASH and to Advance Two Additional SEFAs into the Clinic
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
